Analysis of Access to Prescription Data Management Programs Data for Research

Vivian A Lee; Wilson M Compton; Jonathan D Pollock

doi:10.1001/jamanetworkopen.2022.18094

Analysis of Access to Prescription Data Management Programs Data for Research

JAMA Netw Open. 2022 Jun 1;5(6):e2218094. doi: 10.1001/jamanetworkopen.2022.18094.

Authors

Vivian A Lee¹, Wilson M Compton¹, Jonathan D Pollock^{1

2}

Affiliations

¹ National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland.
² Genetics, Epigenetics, and Developmental Neuroscience Branch, Division of Neuroscience and Behavior, National Institute on Drug Abuse, National Institutes of Health, Rockville, Maryland.

Abstract

This cross-sectional study examines the availability of prescription drug monitoring program data for research and whether those data can be linked to other data.

Publication types

Research Support, N.I.H., Extramural

MeSH terms

Analgesics, Opioid
Data Management*
Humans
Prescription Drug Monitoring Programs*
Prescriptions

Substances

Analgesics, Opioid